ArticleBiotechnology letters2026
Improving expression of Photobacterium sp. JT-ISH-224 α2,6-sialyltransferase using ProteinMPNN and machine learning guided combinatory mutagenesis.
Article in Biotechnology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Industrial-scale production of 6'-sialyllactose (6'-SL), a sialylated human milk oligosaccharide, has recently attracted increasing attention. As a crucial enzyme for both microbial synthesis approaches and enzymatic catalysis, several α2,6-sialyltransferases (α2,6-SiaTs) have been reported and characterized. However, the low expression levels and poor stability of α2,6-SiaTs remain major bottlenecks in the construction of efficient 6'-SL production systems. In this study, we applied a deep-learning-based protein generative model, ProteinMPNN, to redesign an α2,6-SiaT from Photobacterium sp. JT-ISH-224 (pst6-224), resulting in a marked improvement in its heterologous expression in Escherichia coli BL21(DE3). Furthermore, machine learning-guided combinatorial mutagenesis was employed to restore catalytic activity in the redesigned enzyme. The expression level of the final variant was increased by approximately tenfold compared with that of the wild-type pst6-224, and a higher 6'-SL titer was achieved in a 1 L cascade catalytic system starting from CMP. This work demonstrates the potential of machine learning-assisted protein engineering and provides an α2,6-SiaT variant with high expression levels for the biological synthesis of 6'-SL.
Indexed as
Identifiers
42489741What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.